1. PRAC meeting highlights February 2022

   News item 26 February 2022 Pages: 1 - 1

2. Risk of hypoglycaemia with methadone use

   News item 26 February 2022 Pages: 2 - 2

3. US FDA has concerns about safety of compounded ketamine nasal spray

   News item 26 February 2022 Pages: 3 - 3

4. AEs and medication errors in emergency medical services setting

   Clinical study 26 February 2022 Pages: 4 - 4

5. High risk of serious morbidity, mortality from clozapine-induced gastrointestinal hypomotility

   Clinical study 26 February 2022 Pages: 5 - 5

6. HLA-B*07:02 and HLA-C*07:02 associated with cotrimoxazole-induced respiratory failure

   Clinical study 26 February 2022 Pages: 6 - 6

7. Nivolumab plus ipilimumab: fewer AEs with lower dose ipilimumab

   Clinical study 26 February 2022 Pages: 7 - 7

8. Postmarketing requirements for new drugs approved by the FDA

   Clinical study 26 February 2022 Pages: 8 - 8

9. Potential drug-drug interactions common in hospital prescriptions in Denmark

   Clinical study 26 February 2022 Pages: 9 - 9

10. PPIs or COX-2 inhibitors reduce risk of gastrointestinal ADRs from NSAID + anticoagulant use

    Clinical study 26 February 2022 Pages: 10 - 10

11. Serious fluoroquinolone-related ADRs associated with high costs

    Clinical study 26 February 2022 Pages: 11 - 11

12. Therapeutic and recreational cannabinoid use associated with acute pancreatitis

    Clinical study 26 February 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 26 February 2022 Pages: 13 - 13

14. Acetazolamide

    Case report 26 February 2022 Pages: 14 - 14

15. Acetazolamide/dorzolamide

    Case report 26 February 2022 Pages: 15 - 15

16. Acitretin/adalimumab

    Case report 26 February 2022 Pages: 16 - 16

17. Adalimumab

    Case report 26 February 2022 Pages: 17 - 17

18. Adenosine/procainamide

    Case report 26 February 2022 Pages: 18 - 18

19. Afatinib/docetaxel/trastuzumab-emtansine

    Case report 26 February 2022 Pages: 19 - 19

20. Afatinib/necitumumab/zanubrutinib

    Case report 26 February 2022 Pages: 20 - 20

21. Albumin human/terlipressin

    Case report 26 February 2022 Pages: 21 - 21

22. Albumin-human/midodrine/octreotide

    Case report 26 February 2022 Pages: 22 - 22

23. Alemtuzumab

    Case report 26 February 2022 Pages: 23 - 23

24. Alemtuzumab

    Case report 26 February 2022 Pages: 24 - 24

25. Alprostadil

    Case report 26 February 2022 Pages: 25 - 25

26. Alteplase/eptifibatide

    Case report 26 February 2022 Pages: 26 - 26

27. Amantadine

    Case report 26 February 2022 Pages: 27 - 27

28. Amiodarone

    Case report 26 February 2022 Pages: 28 - 28

29. Amiodarone/epinephrine/milrinone

    Case report 26 February 2022 Pages: 29 - 29

30. Amiodarone/flecainide

    Case report 26 February 2022 Pages: 30 - 30

31. Amitriptyline overdose

    Case report 26 February 2022 Pages: 31 - 31

32. Amlodipine overdose

    Case report 26 February 2022 Pages: 32 - 32

33. Amlodipine overdose

    Case report 26 February 2022 Pages: 33 - 33

34. Amoxicillin/clavulanic-acid/azithromycin/lopinavir/ritonavir

    Case report 26 February 2022 Pages: 34 - 34

35. Anaesthetics/bepridil

    Case report 26 February 2022 Pages: 35 - 35

36. Anti-infectives/steroids/tocilizumab

    Case report 26 February 2022 Pages: 36 - 36

37. Anti-inflammatories/antineoplastics

    Case report 26 February 2022 Pages: 37 - 37

38. Anti-inflammatories/moxifloxacin/timolol

    Case report 26 February 2022 Pages: 38 - 38

39. Antiarrhythmics/potassium chloride

    Case report 26 February 2022 Pages: 39 - 39

40. Antibacterials

    Case report 26 February 2022 Pages: 40 - 40

41. Antibacterials

    Case report 26 February 2022 Pages: 41 - 41

42. Antibacterials/antineoplastics

    Case report 26 February 2022 Pages: 42 - 42

43. Antibacterials/dexamethasone

    Case report 26 February 2022 Pages: 43 - 43

44. Antidepressants drugs

    Case report 26 February 2022 Pages: 44 - 44

45. Antidepressants/lorazepam/methylthioninium chloride

    Case report 26 February 2022 Pages: 45 - 45

46. Antiepileptic-drugs

    Case report 26 February 2022 Pages: 46 - 46

47. Antiepileptics

    Case report 26 February 2022 Pages: 47 - 47

48. Antiglaucomas/nepafenac

    Case report 26 February 2022 Pages: 48 - 48

49. Antihyperglycaemics

    Case report 26 February 2022 Pages: 49 - 49

50. Antihypertensives

    Case report 26 February 2022 Pages: 50 - 50